YU43290B - Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrine - Google Patents
Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrineInfo
- Publication number
- YU43290B YU43290B YU1932/86A YU193286A YU43290B YU 43290 B YU43290 B YU 43290B YU 1932/86 A YU1932/86 A YU 1932/86A YU 193286 A YU193286 A YU 193286A YU 43290 B YU43290 B YU 43290B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- inclusioned
- ibuproxane
- cyclodextrine
- beta
- preparing
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Pain & Pain Management (AREA)
- Crystallography & Structural Chemistry (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
YU1932/86A YU43290B (en) | 1986-11-13 | 1986-11-13 | Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrine |
DE87116738T DE3787703D1 (de) | 1986-11-13 | 1987-11-12 | Inklusionskomplex von Ibuproxam mit beta-Cyclodextrin, Verfahren zur Herstellung und diesen Inklusionskomplex enthaltendes pharmazeutisches Präparat. |
AU81173/87A AU605517B2 (en) | 1986-11-13 | 1987-11-12 | Inclusion complex of ibuproxam with beta-cyclodextrin, a process for preparing the same and a pharmaceutical preparation containing the same |
EP87116738A EP0268215B1 (fr) | 1986-11-13 | 1987-11-12 | Complexe d'inclusion de bêta-cyclodextrine avec l'ibuproxame, procédé de préparation et composition pharmaceutique contenant ce complexe |
JP62285683A JPS63183546A (ja) | 1986-11-13 | 1987-11-13 | イブプロキサムとβ‐シクロデキストリンとの包接複合体、その製造法及びそれを含有する医薬製剤 |
US07/119,933 US4952565A (en) | 1986-11-13 | 1987-11-13 | Inclusion complex of ibuproxam with beta-cyclodextrin, a process for preparing the same and a pharmaceutical preparation containing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
YU1932/86A YU43290B (en) | 1986-11-13 | 1986-11-13 | Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrine |
Publications (2)
Publication Number | Publication Date |
---|---|
YU193286A YU193286A (en) | 1988-06-30 |
YU43290B true YU43290B (en) | 1989-06-30 |
Family
ID=25556166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU1932/86A YU43290B (en) | 1986-11-13 | 1986-11-13 | Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrine |
Country Status (6)
Country | Link |
---|---|
US (1) | US4952565A (fr) |
EP (1) | EP0268215B1 (fr) |
JP (1) | JPS63183546A (fr) |
AU (1) | AU605517B2 (fr) |
DE (1) | DE3787703D1 (fr) |
YU (1) | YU43290B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU45837B (sh) * | 1988-01-18 | 1992-07-20 | LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. | Postopek za pripravo novega inkluzijskega kompleksa nikardipina oz. njegovega hidroklorida z beta-ciklodekstrinom |
FR2660309B1 (fr) * | 1990-03-27 | 1992-07-17 | Roussel Uclaf | Nouveaux complexes de l'acide tiaprofenique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs derives. |
US5024997A (en) * | 1990-06-22 | 1991-06-18 | American Home Products Corporation | Palatable ibuprofen solutions |
GB9207990D0 (en) * | 1992-04-10 | 1992-05-27 | Smithkline Beecham Plc | Pharmaceutical composition |
CN1088600C (zh) * | 1993-07-31 | 2002-08-07 | 史密丝克莱恩比彻姆有限公司 | 布洛芬-β-环糊精配合物的用途 |
US5866162A (en) * | 1993-08-10 | 1999-02-02 | Smithkline Beecham P.L.C. | Pharmaceutical composition containing a drug/β-cyclodextrin complex in combination with an acid-base couple |
SI9300470A (en) * | 1993-09-10 | 1995-04-30 | Lek Tovarna Farmacevtskih | Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use |
AU2531295A (en) * | 1994-05-27 | 1995-12-21 | Farmarc Nederland Bv | Pharmaceutical composition |
EP0935669B1 (fr) | 1996-05-20 | 2002-07-31 | Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.V. | Synthese enzymatique d'acides hydroxamiques optiquement actifs et leur conversion en amines primaires optiquement actives par transposition de lossen |
US5942501A (en) * | 1996-08-16 | 1999-08-24 | Collaborative Laboratories, Inc. | Cyclodextrin derivative complex |
US6884885B2 (en) * | 2000-12-21 | 2005-04-26 | Cerestar Holding B.V. | Production of cyclodextrin complexes |
KR100473716B1 (ko) * | 2002-03-27 | 2005-03-08 | 주식회사 참 존 | 7-디하이드로콜레스테롤 및 사이클로덱스트린의 포접복합체, 이를 포함하는 화장료 조성물 및7-디하이드로콜레스테롤의 안정화방법 |
JP4847711B2 (ja) * | 2004-04-16 | 2011-12-28 | 株式会社日立ハイテクノロジーズ | 荷電粒子線装置 |
KR20160033796A (ko) * | 2006-03-28 | 2016-03-28 | 자블린 파머슈티칼스 인코포레이티드 | 저 복용량의 디클로페낙 및 베타-사이클로덱스트린 제형 |
ITRM20070038A1 (it) * | 2007-01-26 | 2008-07-27 | Uni Degli Studi Di Roma La Sapienza | Forme solubili di complessi di inclusione di inibitori dell istone deacetilasi e ciclodestrine loro processi di preparazione e impieghi in campo farmaceutico |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4082707A (en) * | 1973-01-08 | 1978-04-04 | Societa Italo-Britannica L. Manetti-H. Roberts & Co. | 2-(4-isobutylphenyl)-propiohydroxamic acid and a procedure for its preparation |
GB1447658A (en) * | 1973-01-08 | 1976-08-25 | Manetti & Roberts Italo Brit | 2- 4- isobutylphenyl- propionic acid derivative |
US4061668A (en) * | 1974-12-06 | 1977-12-06 | Societa Italo-Britannica L. Manetti - H. Roberts & C. | Process for the preparation of 2-(4-isobutylphenyl)-propiohydroxamic acid |
HU176215B (en) * | 1978-01-27 | 1981-01-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1 |
JPS5592341A (en) * | 1979-01-05 | 1980-07-12 | Kaken Pharmaceut Co Ltd | Preparation of clathrate compound |
JPS5920230A (ja) * | 1982-07-19 | 1984-02-01 | チバ−ガイギ−・アクチエンゲゼルシヤフト | ピルプロフエン含有薬剤 |
IT1196033B (it) * | 1984-02-22 | 1988-11-10 | Chiesi Farma Spa | Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche |
GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
-
1986
- 1986-11-13 YU YU1932/86A patent/YU43290B/xx unknown
-
1987
- 1987-11-12 EP EP87116738A patent/EP0268215B1/fr not_active Expired - Lifetime
- 1987-11-12 DE DE87116738T patent/DE3787703D1/de not_active Expired - Lifetime
- 1987-11-12 AU AU81173/87A patent/AU605517B2/en not_active Ceased
- 1987-11-13 JP JP62285683A patent/JPS63183546A/ja active Pending
- 1987-11-13 US US07/119,933 patent/US4952565A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU605517B2 (en) | 1991-01-17 |
AU8117387A (en) | 1988-05-19 |
YU193286A (en) | 1988-06-30 |
JPS63183546A (ja) | 1988-07-28 |
DE3787703D1 (de) | 1993-11-11 |
US4952565A (en) | 1990-08-28 |
EP0268215A1 (fr) | 1988-05-25 |
EP0268215B1 (fr) | 1993-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG18230A (en) | Process for preparing 3-aryloxy-3-substituted propanamines | |
YU34587A (en) | Process for preparing purinic nucleozides | |
NZ221811A (en) | Process and intermediate for preparing sucrose-6-acylates | |
PT84831A (en) | Process for the preparation of new pyrazol-3-amines | |
CS479187A2 (en) | Process for preparing derivatives of 2-brom-alpha-ergo-cryptine | |
PT85993A (en) | Process for preparing 3-pyrrolidinols | |
YU43290B (en) | Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrine | |
EP0245960A3 (en) | Process for preparing n-acyltetrahydroisoquinoline | |
HU896623D0 (en) | Process for preparation of fluorinated-diphenyl-ethers | |
YU119887A (en) | Process for preparing dihydroizoquinolines | |
HU895128D0 (en) | Process for preparation of oxazolidine- and imidazolidine-derivatives | |
EP0255904A3 (en) | Process for the preparation of dihydrocyclocitral | |
EP0264089A3 (en) | Process for the preparation of sulphatobetaines | |
PT84553A (en) | Process for preparing indenopyrimidine derivatives | |
HU896622D0 (en) | Process for preparation of 3-benzyl-4-fluor-benzaldehyde | |
PT85190A (en) | Process for the preparation of mercaptoacylproline | |
HUT44238A (en) | Process for preparing 1-aryl-5-amino-pyrazole derivatives | |
EP0240741A3 (en) | Process for the preparation of inulase | |
YU213887A (en) | Process for preparing new 1-aryloxi-3-amino-2-propanoles | |
PT86424A (en) | Process for preparing substituted tetrahydropyridoindoles | |
GB8730269D0 (en) | Process for preparing 16-dehydro-20-oxipregnane derivatives | |
GB2191773B (en) | Process for the preparation of 4-alkoxy-3-pyrrolin-2-ones | |
YU104687A (en) | Process for preparing platinum complex of dichlorodimethionine | |
PT84383A (en) | Process for preparing substituted pyrimidoindoles | |
GR870645B (en) | Process for preparing novel ergolene derivatives |